Biocartis Group NV

AGM Information • May 13, 2022

Free English translation for information purposes only

Limited Liability Company ("Naamloze vennootschap") Registered Office: Generaal de Wittelaan 11B, 2800 Mechelen, Belgium Company Number VAT BE 0505.640.808 RLP Antwerp, division Mechelen

MINUTES OF THE ANNUAL SHAREHOLDERS' MEETING HELD ON 13 MAY 2022

____________________________________________

____________________________________________

On 13 May 2022, the annual shareholders' meeting of Biocartis Group NV (the "Company") is held at the offices of the Company at Generaal de Wittelaan 11B, 2800 Mechelen, Belgium.

OPENING OF THE MEETING

The shareholders' meeting is called to order at 2:00 p.m. CEST by the Chairman of the meeting, Luc Gijsens BV, permanently represented by Mr. Luc Gijsens, director of the Company.

The Chairman notes that, in accordance with applicable law, Dutch is the applicable working language for the meeting.

COMPOSITION OF THE BUREAU

In accordance with the Company's articles of association, the Chairman of the meeting designates Mr. Tim Vandorpe as secretary of the meeting. Upon the proposal of the Chairman, the meeting appoints the following person as teller: Mr. Maxim Vancoillie. In view of the limited amount of people present at the meeting, only one teller is appointed.

The Chairman of the meeting and the secretary and teller together constitute the bureau of the annual shareholders' meeting.

In addition, the following directors of the Company are present: South Bay Ventures BV, permanently represented by Mr. Herman Verrelst, CEO of the Company, and Mr. Roald Borré.

The auditor of the Company, Deloitte Bedrijfsrevisoren BV, represented by Nico Houthaeve, is also present.

DECLARATIONS BY THE CHAIRMAN

The Chairman makes the following declarations with respect to the convening and composition of the meeting.

Agenda

The meeting was convened with the following agenda and proposed resolutions:

1. Reports on the statutory financial statements and on the consolidated financial statements

Submission of, and discussion on: (a) the combined annual report of the Board of Directors on the statutory financial statements and the consolidated financial statements for the financial year ended on 31 December 2021, (b) the report of the statutory auditor on the statutory financial statements for the financial year ended on 31 December 2021, and (c) the report of the statutory auditor on the consolidated financial statements for the financial year ended on 31 December 2021.

2. Approval of the statutory financial statements

Approval of the statutory financial statements for the financial year ended on 31 December 2021, and of the proposed allocation of the result.

Proposed resolution: The annual shareholders' meeting approves the statutory financial statements for the financial year ended on 31 December 2021, as well as the allocation of the result as proposed by the Board of Directors.

3. Consolidated financial statements

Submission of, and discussion on, the consolidated financial statements for the financial year ended on 31 December 2021.

4. Discharge from liability of the directors

Proposed resolution: The annual shareholders' meeting grants discharge from liability to each of the directors (including each of the former directors) who was in office during the financial year ended on 31 December 2021, for the performance of his or her mandate during that financial year.

5. Discharge from liability of the statutory auditor

Proposed resolution: The annual shareholders' meeting grants discharge from liability to the statutory auditor for the performance of its mandate during the financial year ended on 31 December 2021.

6. Remuneration report

Submission of, discussion on and approval of the remuneration report prepared by the Remuneration and Nomination Committee, and included in the annual report of the Board of Directors for the financial year ended on 31 December 2021.

Proposed resolution: The annual shareholders' meeting approves the remuneration report included in the annual report of the Board of Directors for the financial year ended on 31 December 2021.

7. Appointment of a director

On 14 May 2021, Herman Verrelst was re-appointed as director of the Company for a term of four years, up to and including the closing of the annual shareholders' meeting to be held in 2025 which will have decided upon the financial statements for the financial year ended on 31 December 2024. With effect as of 1 April 2022, Herman Verrelst resigned as director, but at his request South Bay Ventures BV (in short, SBV BV), a company controlled by Herman Verrelst, was appointed as director by the Board of Directors of the Company to replace Herman Verrelst as director of the Company. In view hereof, and taking into account the recommendation of the Remuneration and Nomination Committee, the Board of Directors recommends that the appointment of South Bay Ventures BV, permanently represented by Herman Verrelst, be confirmed. For further information regarding Herman Verrelst,

reference is made to the corporate governance statement included in the annual report of the Board of Directors for the financial year ended on 31 December 2021.

Proposed resolution: The annual shareholders' meeting takes note of the resignation of Herman Verrelst as director of the Company with effect as of 1 April 2022, and confirms the appointment of South Bay Ventures BV (in short, SBV BV), permanently represented by Herman Verrelst, for a term of three years up to and including the closing of the annual shareholders' meeting to be held in 2025 which will have decided upon the financial statements for the financial year ended on 31 December 2024. While the mandate of South Bay Ventures BV, permanently represented by Herman Verrelst, as Chief Executive Officer shall be remunerated, its mandate as director shall not be remunerated.

8. Re-appointment of directors

Taking into account the recommendation of the Remuneration and Nomination Committee, the Board of Directors recommends that Ann-Christine Sundell, Christine Kuslich and Luc Gijsens BV, represented by Luc Gijsens as permanent representative, be re-appointed as independent directors of the Company for a term of two years, and that Roald Borré be re-appointed as director of the Company for a term of two years. For further information regarding these directors, reference is made to the corporate governance statement included in the annual report of the Board of Directors for the financial year ended on 31 December 2021. Based on information made available by respectively Ann-Christine Sundell, Christine Kuslich and Luc Gijsens BV, permanently represented by Luc Gijsens, it appears that respectively Ann-Christine Sundell, Christine Kuslich and each of Luc Gijsens BV and Luc Gijsens, satisfy the applicable requirements in order to be appointed as independent directors in accordance with Article 7:87 of the Belgian Code of Companies and Associations and provision 3.5 of the Belgian Corporate Governance Code 2020.Based on information made available by Christian Reinaudo, it appears that Christian Reinaudo satisfies the applicable requirements in order to be appointed as independent director in accordance with Article 7:87 of the Belgian Code of Companies and Associations and provision 3.5 of the Belgian Corporate Governance Code 2020.

Proposed resolutions:

• (i) Ann-Christine Sundell is re-appointed as independent director of the Company within the meaning of Article 7:87 of the Belgian Code of Companies and Associations and provision 3.5 of the Belgian Corporate Governance Code 2020, for a term of two years, up to and including the closing of the annual shareholders' meeting to be held in 2024 which will have decided upon the financial statements for the financial year ended on 31 December 2023.
• (ii) Christine Kuslich is re-appointed as independent director of the Company within the meaning of Article 7:87 of the Belgian Code of Companies and Associations and provision 3.5 of the Belgian Corporate Governance Code 2020, for a term of two years, up to and including the closing of the annual shareholders' meeting to be held in 2024 which will have decided upon the financial statements for the financial year ended on 31 December 2023.
• (iii) Luc Gijsens BV, a private company with limited liability under Belgian law, represented by Luc Gijsens as permanent representative, is re-appointed as independent director of the Company within the meaning of Article 7:87 of the Belgian Code of Companies and Associations and provision 3.5 of the Belgian Corporate Governance Code 2020, for a term of two years, up to and including the closing of the annual shareholders' meeting to be held in 2024 which will have decided upon the financial statements for the financial year ended on 31 December 2023.
• (iv) Roald Borré is re-appointed as director of the Company for a term of two years, up to and including the closing of the annual shareholders' meeting to be held in 2024 which will have decided upon the financial statements for the financial year ended on 31 December 2023.

The remuneration of the abovementioned directors is as decided by the general shareholders' meeting held on 11 May 2018 and 14 May 2021.

9. Remuneration of the statutory auditor for financial year ended on 31 December 2021

Proposed resolution: The annual shareholders' meeting resolves to approve the increase of the annual remuneration of the statutory auditor from EUR 142,185.00 (exclusive of expenses and VAT), as approved by the annual shareholders' meeting of 14 May 2021, to EUR 161,415.00 (exclusive of expenses and VAT) for the audit of the statutory annual accounts, the consolidated annual accounts and the interim reporting of the group for the financial year ended on 31 December 2021. This increase results from the fact that the scope of the audit activities performed by the statutory auditor was broadened as a result of the growing business of the group.

Notices Convening the Meeting

The notices convening this annual shareholders' meeting, containing amongst others the agenda and the proposed resolutions and other information, provided for in the Belgian Code of Companies and Associations, have been published in:

• the Belgian Official Gazette on 12 April 2022
• De Standaard on 12 April 2022

Copies of the publications are submitted to the bureau and initialed by the members of the bureau. These will be kept in the files of the Company together with the minutes of this meeting.

The notices convening the annual shareholders' meeting have also been sent at least thirty (30) calendar days before the date of the meeting to the directors of the Company, the statutory auditor of the Company and the holders of securities of the Company, in accordance with applicable law. Proof of the convening notice is being submitted to the bureau and initialled by the bureau. The proof will be safeguarded in the Company's files together with the minutes of this meeting.

In addition, as from 12 April 2022, the following documentation has been made available to the public and the holders of securities issued by the Company on the Company's website (https://investors.biocartis.com/en/shareholders), as announced by way of press release dated 12 April 2022:

• the convening notice;
• an overview with the total number of outstanding shares and voting rights;
• a proxy form to allow holders of shares issued by the Company to be represented at the shareholders' meeting by a proxy holder;
• a form for voting by mail; and
• the documents to be submitted to the shareholders' meeting as referred to in the agenda.

The proof will be kept in the files of the Company together with the minutes of this meeting. The Company has not received any requests, in accordance with the Belgian Code of Companies and Associations, from shareholders who alone or together with other shareholders hold at least 3% of the share capital to put additional items on the agenda of this annual shareholders' meeting and/or to table draft resolutions in relation to items that have been or were to be included in the agenda.

Attendance List

The registration date of the annual shareholders' meeting was Friday 29 April 2022, at midnight (12.00 a.m. CEST). In accordance with the applicable legislation, only persons owning securities issued by the Company on the aforementioned registration date shall be entitled to participate and, as the case may be, vote at the annual shareholders' meeting.

An attendance list has been prepared indicating (i) the identity of the shareholders who participate in the meeting, (ii) the domicile or registered office of such shareholders, (iii) if applicable, the identity of the proxy holders of such shareholders, and (iv) the number of shares with which such shareholders are participating in the voting. The attendance list also indicates the directors who are present at the meeting and whether or not the statutory auditor is present. The attendance list has been signed by the shareholders and the directors, or their proxy holders. There are no holders of subscription rights or convertible bonds who participate in the meeting in an advisory capacity.

In addition, a register has been prepared in which for each shareholder having notified its intention to participate to the shareholders' meeting the following information was included: (i) its name and address or registered office, (ii) the number of shares that it owned on the registration date, and (iii) a description of the documents which indicate that it owned the shares on the registration date.

A separate list has been prepared for the shareholders who have validly submitted their votes by mail in accordance with the Belgian Code of Companies and Associations and the articles of association of the Company, and as set out in the notice convening the annual shareholders' meeting.

The attendance list, the register and the list of the shareholders who have voted by mail are submitted to the bureau, and are subsequently closed, initialed and signed by the members of the bureau. The attendance list, the register, the list of shareholders who have validly voted by mail as well as the votes by mail that have been validly filed with the Company, will be kept in the files of the Company together with the minutes of this meeting.

All holders of securities issued by the Company who are represented at the meeting, included in the aforementioned lists, have complied with the formalities in order to participate in the annual shareholders' meeting in accordance with the Company's articles of association and the Belgian Code of Companies and Associations and as set out in the convening notice.

The certificates which have been filed with respect to dematerialized shares, the letters submitted with respect to registered shares (as the case may be), and the votes by mail and the proxies that have been submitted by the shareholders, will be kept in the files of the Company together with the minutes of this meeting.

Attendance

The Company's share capital amounts to EUR 575,456.63, and is represented by 57,545,663 shares, without nominal value, each representing the same fraction of the Company's share capital. Based on the aforementioned attendance list and the verification of the admission to the annual shareholders' meeting, it appears that 16,937,033 shares in total or 29.4% of the outstanding and existing shares, are present or represented at the meeting.

Quorum and Voting

According to the Belgian Code of Companies and Associations, there is no quorum requirement for the deliberation and voting on the respective items referred to in the aforementioned agenda of the annual shareholders' meeting.

Each of the proposed resolutions under the respective items included in the aforementioned agenda shall be passed if it is approved by a simple majority of the votes validly cast.

Each share is entitled to one vote.

Third Parties Admitted to the Meeting

Apart from the holders of securities who are admitted to the meeting, a number of persons attend the meeting, such as certain members of the staff of the Company. The aforementioned persons have signed an attendance list regarding persons who are not a shareholder or who are a shareholder but have not complied with the formalities to be admitted to the meeting.

VERIFICATION OF THE CONVENING AND COMPOSITION OF THE MEETING

The aforementioned statements by the Chairman are verified and approved by the meeting. Subsequently, the annual shareholders' meeting determines and confirms that it has been validly convened and is validly constituted, and that it is authorized to deliberate and vote on the items on the agenda of the meeting.

DELIBERATIONS AND VOTING

Upon proposal by the secretary, the meeting begins with the deliberation on the items on the agenda.

Submission of Documentation

The secretary of the meeting submits to the meeting the following documentation that has been mentioned in the first items on the agenda of the meeting:

• − the combined annual report of the Board of Directors on the statutory financial statements and the consolidated financial statements for the financial year ended on 31 December 2021, which includes the consolidated financial statements for the financial year ended on 31 December 2021;
• − the report of the statutory auditor on the statutory financial statements for the financial year ended on 31 December 2021;
• − the report of the statutory auditor on the consolidated financial statements for the financial year ended on 31 December 2021;
• − the statutory financial statements of the Company for the financial year ended on 31 December 2021; and
• − the remuneration report.

The secretary states that these documents have been made available to the directors, the statutory auditor and the holders of securities issued by the Company in accordance with the Company's articles of association and the Belgian Code of Companies and Associations. The secretary also states that these documents have been made available to the holders of securities issued by the Company and the public on the Company's website. The documents concerned will be kept in the files of the Company together with the minutes of this meeting.

The meeting takes note of the fact that this documentation has been submitted. The meeting releases the secretary from reading the documentation that has been submitted.

The meeting takes note of the presentation by the CEO and the CFO of the Company in connection with the activities and the financial result of the Company over 2021. The presentation of the CEO and the CFO will be kept in the files of the Company, together with the minutes of this meeting.

Questions

After the aforementioned presentation and explanation, the meeting is given the opportunity to ask questions with respect to the documents that have been submitted to this annual shareholders' meeting and with respect to the items on the agenda of this annual shareholders' meeting. In response to the questions that are asked by the holders of shares issued by the Company with respect to the various items on the agenda of this annual shareholders' meeting and the documents that are submitted to this annual shareholders' meeting, additional explanation is given by the Chairman of the meeting and by the CEO and CFO of the Company.

Deliberations and Voting

Subsequently, upon proposal of the secretary, the meeting proceeds with the deliberation and voting with respect to the respective items on the agenda.

The items on the agenda are separately deliberated upon.

1. Reports on the statutory financial statements and on the consolidated financial statements

Submission of, and discussion on: (a) the combined annual report of the Board of Directors on the statutory financial statements and the consolidated financial statements for the financial year ended on 31 December 2021, (b) the report of the statutory auditor on the statutory financial statements for the financial year ended on 31 December 2021, and (c) the report of the statutory auditor on the consolidated financial statements for the financial year ended on 31 December 2021.

This agenda item requires no further resolution.

2. Approval of the statutory financial statements

Approval of the statutory financial statements for the financial year ended on 31 December 2021, and of the proposed allocation of the result.

After deliberation, the following resolution is passed with a majority of 100%:

The annual shareholders' meeting approves the statutory financial statements for the financial year ended on 31 December 2021, as well as the allocation of the result as proposed by the Board of Directors.

This resolution is passed as follows:

-	votes approving:	16,907,086
-	votes disapproving:	0
-	abstentions:	29,947

16,937,033 valid votes have been registered for 57,545,663 shares, which represents 29.4% of the share capital.

3. Consolidated financial statements

Submission of, and discussion on, the consolidated financial statements for the financial year ended on 31 December 2021.

This agenda item requires no further resolution.

4. Discharge from liability of the directors

Upon proposal of the Chairman, the meeting decides to vote collectively for all of the directors concerned with respect to this agenda item.

After deliberation, the following resolution is passed with a majority of 100%:

The annual shareholders' meeting grants discharge from liability to each of the directors (including each of the former directors) who was in office during the financial year ended on 31 December 2021, for the performance of his or her mandate during that financial year.

This resolution is passed as follows:

• votes approving: 16,907,086
• votes disapproving: 0
• abstentions: 29,947

16,937,033 valid votes have been registered for 57,545,663 shares, which represents 29.4% of the share capital.

5. Discharge from liability of the statutory auditor

After deliberation, the following resolution is passed with a majority of 100%:

The annual shareholders' meeting grants discharge from liability to the statutory auditor for the performance of its mandate during the financial year ended on 31 December 2021.

This resolution is passed as follows:

• votes approving: 16,907,086

• votes disapproving: 0

• abstentions: 29,947

16,937,033 valid votes have been registered for 57,545,663 shares, which represents 29.4% of the share capital.

6. Remuneration report

Submission of, discussion on and approval of the remuneration report prepared by the Remuneration and Nomination Committee, and included in the annual report of the Board of Directors for the financial year ended on 31 December 2021.

After deliberation, the following resolution is passed with a majority of 92.04%:

The annual shareholders' meeting approves the remuneration report included in the annual report of the Board of Directors for the financial year ended on 31 December 2021

This resolution is passed as follows:

-	votes approving:	15,558,808
-	votes disapproving:	1,346,278
-	abstentions:	31,947

16,937,033 valid votes have been registered for 57,545,663 shares, which represents 29.4% of the share capital.

7. Appointment of a director

On 14 May 2021, Herman Verrelst was re-appointed as director of the Company for a term of four years, up to and including the closing of the annual shareholders' meeting to be held in 2025 which will have decided upon the financial statements for the financial year ended on 31 December 2024. With effect as of 1 April 2022, Herman Verrelst resigned as director, but at his request South Bay Ventures BV (in short, SBV BV), a company controlled by Herman Verrelst, was appointed as director by the Board of Directors of the Company to replace Herman Verrelst as director of the Company. In view hereof, and taking into account the recommendation of the Remuneration and Nomination Committee, the Board of Directors recommends that the appointment of South Bay Ventures BV, permanently represented by Herman Verrelst, be confirmed. For further information regarding Herman Verrelst, reference is made to the corporate governance statement included in the annual report of the Board of Directors for the financial year ended on 31 December 2021.

After deliberation, the following resolution is passed with a majority of 100%:

The annual shareholders' meeting takes note of the resignation of Herman Verrelst as director of the Company with effect as of 1 April 2022, and confirms the appointment of South Bay Ventures BV (in short, SBV BV), permanently represented by Herman Verrelst, for a term of three years up to and including the closing of the annual shareholders' meeting to be held in 2025 which will have decided upon the financial statements for the financial year ended on 31 December 2024. While the mandate of South Bay Ventures BV, permanently represented by Herman Verrelst, as Chief Executive Officer shall be remunerated, its mandate as director shall not be remunerated.

This resolution is passed as follows:

• votes approving: 16,906,986
• votes disapproving: 0
• abstentions: 30,047

16,937,033 valid votes have been registered for 57,545,663 shares, which represents 29.4% of the share capital.

8. Re-appointment of directors

Taking into account the recommendation of the Remuneration and Nomination Committee, the Board of Directors recommends that Ann-Christine Sundell, Christine Kuslich and Luc Gijsens BV, represented by Luc Gijsens as permanent representative, be re-appointed as independent directors of the Company for a term of two years, and that Roald Borré be re-appointed as director of the Company for a term of two years. For further information regarding these directors, reference is made to the corporate governance statement included in the annual report of the Board of Directors for the financial year ended on 31 December 2021.

Based on information made available by respectively Ann-Christine Sundell, Christine Kuslich and Luc Gijsens BV, permanently represented by Luc Gijsens, it appears that respectively Ann-Christine Sundell, Christine Kuslich and each of Luc Gijsens BV and Luc Gijsens, satisfy the applicable requirements in order to be appointed as independent directors in accordance with Article 7:87 of the Belgian Code of Companies and Associations and provision 3.5 of the Belgian Corporate Governance Code 2020.

(i) After deliberation, the following resolution is passed with a majority of 100%:

Ann-Christine Sundell is re-appointed as independent director of the Company within the meaning of Article 7:87 of the Belgian Code of Companies and Associations and provision 3.5 of the Belgian Corporate Governance Code 2020, for a term of two years, up to and including the closing of the annual shareholders' meeting to be held in 2024 which will have decided upon the financial statements for the financial year ended on 31 December 2023.

This resolution is passed as follows:

• votes approving: 16,907,086
• votes disapproving: 0
• abstentions: 29,947

16,937,033 valid votes have been registered for 57,545,663 shares, which represents 29.4% of the share capital.

(ii) After deliberation, the following resolution is passed with a majority of 100%:

Christine Kuslich is re-appointed as independent director of the Company within the meaning of Article 7:87 of the Belgian Code of Companies and Associations and provision 3.5 of the Belgian Corporate Governance Code 2020, for a term of two years, up to and including the closing of the annual shareholders' meeting to be held in 2024 which will have decided upon the financial statements for the financial year ended on 31 December 2023.

This resolution is passed as follows:

• votes approving: 16,907,086
• votes disapproving: 0
• abstentions: 29,947

16,937,033 valid votes have been registered for 57,545,663 shares, which represents 29.4% of the share capital.

(iii) After deliberation, the following resolution is passed with a majority of 100%:

Luc Gijsens BV, a private company with limited liability under Belgian law, represented by Luc Gijsens as permanent representative, is re-appointed as independent director of the Company within the meaning of Article 7:87 of the Belgian Code of Companies and Associations and provision 3.5 of the Belgian Corporate Governance Code 2020, for a term of two years, up to and including the closing of the annual shareholders' meeting to be held in 2024 which will have decided upon the financial statements for the financial year ended on 31 December 2023.

This resolution is passed as follows:

• votes approving: 16,906,519
• votes disapproving: 467
• abstentions: 30,047

16,937,033 valid votes have been registered for 57,545,663 shares, which represents 29.4% of the share capital.

(iv) After deliberation, the following resolution is passed with a majority of 60.96%:

Roald Borré is re-appointed as director of the Company for a term of two years, up to and including the closing of the annual shareholders' meeting to be held in 2024 which will have decided upon the financial statements for the financial year ended on 31 December 2023:

-	votes approving:	10,305,929

• votes disapproving: 6,601,157
• abstentions: 29,947

16,937,033 valid votes have been registered for 57,545,663 shares, which represents 29.4% of the share capital.

The remuneration of the abovementioned directors is as decided by the general shareholders' meeting held on 11 May 2018 and 14 May 2021.

The Board of Directors of the Company at the closing of the shareholders' meeting shall consequently be composed as follows:

• Christian Reinaudo, appointed for a term up to and including the annual shareholders' meeting to be held in 2024
• South Bay Ventures BV, permanently represented by Herman Verrelst, appointed for a term up to and including the annual shareholders' meeting to be held in 2025
• Ann-Christine Sundell, appointed for a term up to and including the annual shareholders' meeting to be held in 2024
• Luc Gijsens BV, permanently represented by Luc Gijsens, appointed for a term up to and including the annual shareholders' meeting to be held in 2024
• Christine Kuslich, appointed for a term up to and including the annual shareholders' meeting to be held in 2024
• Roald Borré, appointed for a term up to and including the annual shareholders' meeting to be held in 2024.

9. Remuneration of the statutory auditor for financial year ended on 31 December 2021

After deliberation, the following resolution is passed with a majority of 94.78%:

The annual shareholders' meeting resolves to approve the increase of the annual remuneration of the statutory auditor from EUR 142,185.00 (exclusive of expenses and VAT), as approved by the annual shareholders' meeting of 14 May 2021, to EUR 161,415.00 (exclusive of expenses and VAT) for the audit of the statutory annual accounts, the consolidated annual accounts and the interim reporting of the group for the financial year ended on 31 December 2021. This increase results from the fact that the scope of the audit activities performed by the statutory auditor was broadened as a result of the growing business of the group. This resolution is passed as follows:

• votes approving: 16,024,425
• votes disapproving: 882,661
• abstentions: 29,947

16,937,033 valid votes have been registered for 57,545,663 shares, which represents 29.4% of the share capital.

* * *

There being no further business and since no further items were raised, the meeting is adjourned by the Chairman at 3.30 p.m. CEST.

These minutes are signed in three original copies by the Chairman of the meeting and the other members of the bureau.

Signed by:

[Signed] [

Luc Gijsens BV, Permanently represented by Mr. Luc Gijsens Chairman

Signed]

Mr. Tim Vandorpe Secretary

[Signed]

Mr. Maxim Vancoillie Teller

Annexes

The documentation set out below has been submitted to the bureau of the annual shareholders' meeting, and has been initialed and/or signed by the members of the bureau (where applicable), and will be kept in the files of the Company together with a copy of the minutes of the meeting.

• (A) Proof of the publication of the convening notice in a nation-wide newspaper and the Belgian Official Gazette
• (B) Attendance list
• (C) Register
• (D) List of shareholders voting by mail
• (E) Compliance with the formalities by the participants to the meeting
  • − Certificates that have been submitted with respect to dematerialized shares
  • − Letters that have been submitted with respect to registered shares
  • − Votes by mail
  • − Proxies
• (F) The combined annual report of the Board of Directors on the statutory financial statements and the consolidated financial statements for the financial year ended on 31 December 2021, which includes among others the remuneration report and the consolidated financial statements for the financial year ended on 31 December 2021
• (G) The report of the statutory auditor on the statutory financial statements for the financial year ended on 31 December 2021
• (H) The report of the statutory auditor on the consolidated financial statements for the financial year ended on 31 December 2021
• (I) The statutory financial statements of the Company for the financial year ended on 31 December 2021